P

Inventor

HEBEISEN PAUL

CH49 patents
⚠️ This page may combine multiple inventors who share the name “HEBEISEN PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

28 patents
US7229999B2Jun 12, 2007

Pyridine-3-carboxamide derivatives as CB1 inverse agonists

HOFFMANN LA ROCHE40 citations92
US5804577ASep 8, 1998

Cephalosporin derivatives

HOFFMANN LA ROCHE29 citations90
US6844345B2Jan 18, 2005

Piperazine derivatives

HOFFMANN LA ROCHE15 citations84
US9403808B2Aug 2, 2016

Pyrazine derivatives

HOFFMANN LA ROCHE8 citations80
US7691863B2Apr 6, 2010

Pyrazine-2-carboxamide derivatives as CB2 receptor modulators

HOFFMANN LA ROCHE11 citations80
US6232306B1May 15, 2001

Derivatives of 3-(2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl)-cephams

HOFFMANN LA ROCHE13 citations74
US6583134B2Jun 24, 2003

Aza- indolyl derivatives for treating obesity

HOFFMANN LA ROCHE10 citations73
US5589473ADec 31, 1996

Mono- and bicyclic DNA gyrase inhibitors

HOFFMANN LA ROCHE8 citations73
US5438052AAug 1, 1995

Cephalosporin derivatives

HOFFMANN LA ROCHE11 citations73
US5294609AMar 15, 1994

DNA gyrase inhibitors and pharmaceutical preparations therefor

HOFFMANN LA ROCHE12 citations71
US6610685B2Aug 26, 2003

Fused indole derivatives

HOFFMANN LA ROCHE11 citations70
US5981519ANov 9, 1999

Vinyl-pyrrolidinone cephalosporins

HOFFMANN LA ROCHE12 citations69
US4888429ADec 19, 1989

Process for producing allyl aminothiazole acetate intermediates

HOFFMANN LA ROCHE3 citations63
US7897621B2Mar 1, 2011

2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents

HOFFMANN LA ROCHE4 citations62
US7629346B2Dec 8, 2009

Pyrazinecarboxamide derivatives as CB1 antagonists

HOFFMANN LA ROCHE2 citations62
US5594135AJan 14, 1997

Tricyclic DNA gyrase inhibitors

HOFFMANN LA ROCHE2 citations62
US5055572AOct 8, 1991

Cephalosporin derivatives

HOFFMANN LA ROCHE3 citations62
US5939410AAug 17, 1999

1-carba-(dethia)-cephalosporin derivatives

HOFFMANN LA ROCHE3 citations60
US7812028B2Oct 12, 2010

3-pyridinecarboxamide derivatives as HDL-cholesterol raising agents

HOFFMANN LA ROCHE5 citations59
US5665746ASep 9, 1997

Mono- and bicyclic DNA gyrase inhibitors

HOFFMANN LA ROCHE0 citations51
US5486466AJan 23, 1996

Process for the preparation of DNA gyrase inhibitors

HOFFMANN LA ROCHE0 citations50
US9090599B2Jul 28, 2015

Heteroarylmethyl amides

HOFFMANN LA ROCHE0 citations48
US7323466B2Jan 29, 2008

Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity

HOFFMANN LA ROCHE1 citations48
US7781593B2Aug 24, 2010

5-phenyl-nicotinamide derivatives

HOFFMANN LA ROCHE0 citations42
US7973051B2Jul 5, 2011

Aminothiazoles as FBPase inhibitors for diabetes

HOFFMANN LA ROCHE0 citations39
US7547699B2Jun 16, 2009

Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity

HOFFMANN LA ROCHE0 citations38
US7964633B2Jun 21, 2011

Sulfonamide derivatives

HOFFMANN LA ROCHE0 citations37
US7868030B2Jan 11, 2011

FBPase inhibitors for diabetes

HOFFMANN LA ROCHE0 citations37

VERNALIS RES LTD

4 patents

UNIV BASEL

3 patents

TORQUR AG

3 patents

HEBEISEN PAUL

3 patents

PIQUR THERAPEUTICS AG

2 patents

GRETHER UWE

2 patents

BASILEA PHARMACEUTICA AG

1 patent

BISSANTZ CATERINA

1 patent

ANDJELKOVIC MIRJANA

1 patent

HAAP WOLFGANG

1 patent